Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease.
D000342:Affective Symptoms; D000368:Aged; D001639:Bicarbonates / Q000134:cerebrospinal fluid; D002245:Carbon Dioxide / Q000134:cerebrospinal fluid; D003704:Dementia / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D005260:Female; D006019:Glycolysis; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D007360:Intelligence; D007773:Lactates / Q000134:cerebrospinal fluid*; D008297:Male; D008875:Middle Aged; D009048:Motor Skills; D010300:Parkinson Disease / Q000134:cerebrospinal fluid; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000627:therapeutic use; D011773:Pyruvates / Q000134:cerebrospinal fluid*
D001639:Bicarbonates; D007773:Lactates; D010648:Phenylacetates; D011773:Pyruvates; D002245:Carbon Dioxide; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid; D006719:Homovanillic Acid